🇺🇸 FDA
Patent

US 6132724

Allelic polygene diagnosis of reward deficiency syndrome and treatment

expired A61KA61K33/24A61K36/41

Quick answer

US patent 6132724 (Allelic polygene diagnosis of reward deficiency syndrome and treatment) held by The University of Texas System AMD Board of Regents expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The University of Texas System AMD Board of Regents
Grant date
Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K33/24, A61K36/41, A61K45/06